Novo Nordisk Rebrands Wegovy to Target Lifestyle Weight Loss

By Elaine Chen · STAT News · 2026-09-28

According to reporting from STAT News, pharmaceutical giant Novo Nordisk is pivoting its marketing strategy to position GLP-1 medications as general wellness tools rather than strictly medical interventions for chronic obesity. The manufacturer has updated its digital messaging a

According to reporting from STAT News, pharmaceutical giant Novo Nordisk is pivoting its marketing strategy to position GLP-1 medications as general wellness tools rather than strictly medical interventions for chronic obesity. The manufacturer has updated its digital messaging a